Host immune response in liver in chronic hepatitis C - Both perforin and fas-ligand pathways are activated

被引：0
|
作者：
Bhardwai, G
Ohno, T
Mizokami, M
Gish, RG
Lau, JYN
机构：
[1] UNIV FLORIDA, SECT HEPATOBILIARY DIS, GAINESVILLE, FL USA
[2] NAGOYA CITY UNIV, NAGOYA, AICHI, JAPAN
[3] CALIF PACIFIC MED CTR, SAN FRANCISCO, CA USA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1152 / A1152
页数：1
相关论文
共 50 条
  • [1] Fas-ligand and perforin expression in infiltrating cytotoxic T lymphocytes in the liver of chronic hepatitis C
    Ono, K
    Tanaka, Y
    Kusano, F
    Kakinuma, S
    Ishidate, K
    Watanabe, M
    Marumo, F
    Sato, C
    HEPATOLOGY RESEARCH, 2002, 23 (03) : 153 - 162
  • [2] Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis
    Tagashira, M
    Yamamoto, K
    Fujio, K
    Nagano, T
    Okamoto, R
    Ibuki, N
    Yabushita, K
    Matsumura, S
    Okano, N
    Tsuji, T
    JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (05) : 347 - 353
  • [3] Expression of Perforin and Fas Ligand mRNA in the Liver of Viral Hepatitis
    Masafumi Tagashira
    Kazuhide Yamamoto
    Kozo Fujio
    Takuya Nagano
    Ryoichi Okamoto
    Naofumi Ibuki
    Kazuhisa Yabushita
    Shuji Matsumura
    Nobuaki Okano
    Takao Tsuji
    Journal of Clinical Immunology, 2000, 20 : 347 - 353
  • [4] In situ expression of Granzyme B and Fas-ligand in the liver of viral hepatitis
    Ibuki, N
    Yamamoto, K
    Yabushita, K
    Okano, N
    Okamoto, R
    Shimada, N
    Hakoda, T
    Mizuno, M
    Higashi, T
    Tsuji, T
    LIVER, 2002, 22 (03): : 198 - 204
  • [5] Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response
    Nakajima, H
    Oka, T
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1096 - 1100
  • [6] Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C
    Panasiuk, Anatol
    Parfieniuk, Anna
    Zak, Janusz
    Flisiak, Robert
    LIVER INTERNATIONAL, 2010, 30 (03) : 472 - 478
  • [7] Role of perforin and Fas ligand in the pathogenesis of chronic hepatitis B.
    Okano, N
    Yamamoto, K
    Tagashira, M
    Okamoto, R
    Ibuki, N
    Yabushita, K
    Matsumura, S
    Tsuji, T
    HEPATOLOGY, 1998, 28 (04) : 721A - 721A
  • [8] Activation of both Fas and perforin pathways in rat liver allograft rejection.
    Okuyama, T
    Li, XK
    Yamada, M
    Suzuki, Y
    Tamura, A
    Funeshima, N
    Suzuki, S
    HEPATOLOGY, 1997, 26 (04) : 148 - 148
  • [9] CTL-induced liver disease requires co-stimulation of both the Fas ligand- and perforin-activated death pathways.
    Nakamoto, Y
    Guidotti, LG
    Chisari, FV
    HEPATOLOGY, 1996, 24 (04) : 899 - 899
  • [10] Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis
    Hodgson, PD
    Grant, MD
    Michalak, TI
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (01): : 63 - 70
12345